3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
35
INDUSTRY
8
OTHER_GOV
3
NETWORK
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Dermatologic
1
Conditions
Melanoma
1
Carcinoma, Non-Small-Cell Lung
1
Interventions
Carboplatin
34
Paclitaxel
29
Radiotherapy
23
Cisplatin
23
Docetaxel
18
Pemetrexed
14
Gemcitabine
14
Radiosurgery
10
Bevacizumab
9
Magnetic Resonance Spectroscopy
7
Etoposide
7
Ramucirumab
6
Erlotinib Hydrochloride
6
Cetuximab
6
Specimen Handling
5
Gene Expression Profiling
5
durvalumab
4
cediranib
4
Vinorelbine
4
Polymerase Chain Reaction
4
Amplified Fragment Length Polymorphism Analysis
4
pembrolizumab
3
cemiplimab
3
Watchful Waiting
3
Taxes
3
Surgical Procedures, Operative
3
Radiotherapy, Conformal
3
Psychiatric Rehabilitation
3
Neoadjuvant Therapy
3
Fluorodeoxyglucose F18
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
NETWORK
×
Carcinoma, Non-Small-Cell Lung
×
Immune Checkpoint Inhibitors
×
Clear all
NCT05522660
2026-04-27
USZ-STRIKE
ETOP IBCSG Partners Foundation
Phase 3
Recruiting
180 enrolled